Star Combo Pharma Ltd

Research Star Combo Pharma Ltd (S66) on Bullrun: market cap AUD 18.24M, P/E 4.4, dividend yield 3.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerS66
• ExchangeAU
• CountryAustralia
• SectorConsumer Defensive
• IndustryHousehold & Personal Products
• CurrencyAUD
• Market capAUD 18.24M
• P/E4.4
• Dividend yield3.2%
• Financial periodFY2024
• RevenueAUD 26.02M
• Revenue growth5.3%
• Net incomeAUD 747.33K
• Free cash flow-AUD 1.76M
• Gross margin28.5%

Valuation Snapshot

latest market cap is AUD 18.24M; P/E is 4.4; dividend yield is 3.2%.

About Star Combo Pharma Ltd

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands.

Frequently asked questions

What is Star Combo Pharma Ltd's market cap?

Star Combo Pharma Ltd's market capitalization is AUD 18.24M.

What is Star Combo Pharma Ltd's P/E ratio?

Star Combo Pharma Ltd's price-to-earnings (P/E) ratio is 4.4.

Does Star Combo Pharma Ltd pay a dividend?

Star Combo Pharma Ltd has a dividend yield of 3.2%.

What does Star Combo Pharma Ltd do?

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products.